437 related articles for article (PubMed ID: 18805553)
1. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
Zimmerman MA; Flores SC
J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
[TBL] [Abstract][Full Text] [Related]
2. The endothelial dysfunction in diabetes mellitus.
Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in diabetes mellitus.
Cosentino F; Lüscher TF
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S54-61. PubMed ID: 9883749
[TBL] [Abstract][Full Text] [Related]
4. Nitrotyrosine: new findings as a marker of postprandial oxidative stress.
Ceriello A
Int J Clin Pract Suppl; 2002 Jul; (129):51-8. PubMed ID: 12166608
[TBL] [Abstract][Full Text] [Related]
5. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.
Ortmann J; Nett PC; Celeiro J; Traupe T; Tornillo L; Hofmann-Lehmann R; Haas E; Frank B; Terraciano LM; Barton M
Biochem Biophys Res Commun; 2005 Aug; 334(2):689-95. PubMed ID: 16009335
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes.
Ceriello A; Kumar S; Piconi L; Esposito K; Giugliano D
Diabetes Care; 2007 Mar; 30(3):649-54. PubMed ID: 17327335
[TBL] [Abstract][Full Text] [Related]
9. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
10. [Postprandial hyperglycemia as a risk factor in the development of endothelial dysfunction--how to prevent?].
Ljubić S; Boras J; Vidjak V
Lijec Vjesn; 2008; 130(1-2):21-5. PubMed ID: 18589639
[TBL] [Abstract][Full Text] [Related]
11. Mouse models for studies of cardiovascular complications of type 1 diabetes.
Shen X; Bornfeldt KE
Ann N Y Acad Sci; 2007 Apr; 1103():202-17. PubMed ID: 17376839
[TBL] [Abstract][Full Text] [Related]
12. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
Candido R; Zanetti M
Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):75-9. PubMed ID: 21453785
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and immunity in diabetic vascular complications.
Nilsson J; Bengtsson E; Fredrikson GN; Björkbacka H
Curr Opin Lipidol; 2008 Oct; 19(5):519-24. PubMed ID: 18769234
[TBL] [Abstract][Full Text] [Related]
15. Vascular complications in diabetes mellitus: the role of endothelial dysfunction.
Schalkwijk CG; Stehouwer CD
Clin Sci (Lond); 2005 Aug; 109(2):143-59. PubMed ID: 16033329
[TBL] [Abstract][Full Text] [Related]
16. [Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2].
Knapik-Kordecka M; Piwowar A; Warwas M
Wiad Lek; 2007; 60(7-8):329-34. PubMed ID: 18175551
[TBL] [Abstract][Full Text] [Related]
17. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
[TBL] [Abstract][Full Text] [Related]
19. Protecting the endothelium: a new focus for management of chronic kidney disease.
Diaz-Buxo JA; Woods HF
Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
[TBL] [Abstract][Full Text] [Related]
20. 'Lipoproteins, glycoxidation and diabetic angiopathy'.
Jenkins AJ; Best JD; Klein RL; Lyons TJ
Diabetes Metab Res Rev; 2004; 20(5):349-68. PubMed ID: 15343582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
